These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effects of contrast media on coagulation factor XII. Laurie AJ; Lyon SG; Lasser EC Invest Radiol; 1991 Nov; 26 Suppl 1():S23-5; discussion S40-1. PubMed ID: 1808136 [No Abstract] [Full Text] [Related]
4. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation. Park HS; Gu J; You HJ; Kim JE; Kim HK Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311 [TBL] [Abstract][Full Text] [Related]
5. Synthetic substrates for the assay of prekallikrein and factor XII. Kluft C Methods Enzymol; 1988; 163():170-9. PubMed ID: 3237073 [No Abstract] [Full Text] [Related]
6. Lower factor XII activity is a risk marker rather than a risk factor for cardiovascular disease: a rebuttal. Kanaji T J Thromb Haemost; 2008 Jun; 6(6):1053-4; author reply 1055-6. PubMed ID: 18331454 [No Abstract] [Full Text] [Related]
7. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein. Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465 [TBL] [Abstract][Full Text] [Related]
8. Adult cystic fibrosis patients with and without infective exacerbations and their factor XII levels. Davidson SJ; Paramothayan S; Hodson ME Blood Coagul Fibrinolysis; 2009 Sep; 20(6):400-2. PubMed ID: 19525847 [TBL] [Abstract][Full Text] [Related]
9. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates. Kluft C; Svendsen L; Los P Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367 [No Abstract] [Full Text] [Related]
10. Structural and functional characterization of factor XII. Tans G; Rosing J Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074 [TBL] [Abstract][Full Text] [Related]
11. Identification of a bradykinin-generating hypotensive substance in plasma protein fraction: prekallikrein activator (PKA-beta-Xiia). Bakker JC; de Vries-van Rossen A; Radema H; Bleeker W; Ufkes JG; van Rosevelt RF; van Mourik JA Adv Exp Med Biol; 1983; 156 (Pt B)():1091-7. PubMed ID: 6602466 [No Abstract] [Full Text] [Related]
12. PKA contamination of immunoglobulin G. Eibl MM N Engl J Med; 1985 Aug; 313(9):581. PubMed ID: 3875038 [No Abstract] [Full Text] [Related]
14. Contact activation patterns of human plasma measured with a fluorogenic substrate. Dooijewaard G; Kluft C Adv Exp Med Biol; 1983; 156():115-20. PubMed ID: 6602460 [No Abstract] [Full Text] [Related]
15. Initiation of contact activation by sulfatides. Tans G; Griffin JH Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464 [TBL] [Abstract][Full Text] [Related]
16. Initiation of contact activation of human plasma. Kaplan AP; Dunn JT; Silverberg M Adv Exp Med Biol; 1983; 156():45-61. PubMed ID: 6602463 [No Abstract] [Full Text] [Related]
17. Changes in components of the KK-system after recirculation and the addition of plasma kallikrein. Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE Adv Exp Med Biol; 1989; 247A():481-6. PubMed ID: 2603814 [No Abstract] [Full Text] [Related]
18. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives. RĂžjkaer R; Schousboe I Eur J Biochem; 1997 Jul; 247(2):491-6. PubMed ID: 9266689 [TBL] [Abstract][Full Text] [Related]
19. In vitro assay for prekallikrein activator (PKA). Lundblad JL Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466 [TBL] [Abstract][Full Text] [Related]
20. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen. Schousboe I; Halkier T Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]